Caricamento...
Targeting the Human Epidermal Growth Factor Receptor Family in Breast Cancer beyond HER2
Currently, the dichotomous definition of human epidermal growth factor receptor 2 (HER2)-positive versus HER2-negative disease undergoing a change through inclusion of the identification of the “HER2-low” category, for which new therapeutic compounds in the form of potent antibody drug conjugates (A...
Salvato in:
| Pubblicato in: | Breast Care (Basel) |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
S. Karger GmbH
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7768135/ https://ncbi.nlm.nih.gov/pubmed/33447231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000510998 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|